Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of fallot repair surgery: a randomized controlled trial

Qingping Wu, Tingting Wang, Shiqiang Chen, Quanjun Zhou, Haobo Li, Na Hu, Yinglu Feng, Nianguo Dong, Shanglong Yao, Zhengyuan Xia, Qingping Wu, Tingting Wang, Shiqiang Chen, Quanjun Zhou, Haobo Li, Na Hu, Yinglu Feng, Nianguo Dong, Shanglong Yao, Zhengyuan Xia

Abstract

Aims: Remote ischaemic preconditioning (RIPC) by inducing brief ischaemia in distant tissues protects the heart against myocardial ischaemia-reperfusion injury (IRI) in children undergoing open-heart surgery, although its effectiveness in adults with comorbidities is controversial. The effectiveness and mechanism of RIPC with respect to myocardial IRI in children with tetralogy of Fallot (ToF), a severe cyanotic congenital cardiac disease, undergoing open heart surgery are unclear. We hypothesized that RIPC can confer cardioprotection in children undergoing ToF repair surgery.

Methods and results: Overall, 112 ToF children undergoing radical open cardiac surgery using cardiopulmonary bypass (CPB) were randomized to either a RIPC group (n = 55) or a control group (n = 57). The RIPC protocol consisted of three cycles of 5-min lower limb occlusion and 5-min reperfusion using a cuff-inflator. Serum inflammatory cytokines and cardiac injury markers were measured before surgery and after CPB. Right ventricle outflow tract (RVOT) tissues were collected during the surgery to assess hypoxia-inducible factor (Hif)-1α and other signalling proteins. Cardiac mitochondrial injury was assessed by electron microscopy. The primary results showed that the length of stay in the intensive care unit (ICU) was longer in the control group than in the RIPC group (52.30 ± 13.43 h vs. 47.55 ± 10.34 h, respectively, P = 0.039). Patients in the control group needed longer post-operative ventilation time compared to the RIPC group (35.02 ± 6.56 h vs. 31.96 ± 6.60 h, respectively, P = 0.016). The levels of post-operative serum troponin-T at 12 and 18 h, CK-MB at 24 h, as well as the serum h-FABP levels at 6 h, after CPB were significantly lower, which was coincident with significantly higher protein expression of cardiac Hif-1α, p-Akt, p-STAT3, p-STAT5, and p-eNOS and less vacuolization of mitochondria in the RIPC group compared to the control group.

Conclusion: In ToF children undergoing open heart surgery, RIPC attenuates myocardial IRI and improves the short-term prognosis.

Figures

Figure 1
Figure 1
Trial flow diagram.
Figure 2
Figure 2
Ventilation time curve (A) and ICU stay time curve (B). N = 57 in the control group and N = 55 in the RIPC group. *P < 0.05 vs. control group.
Figure 3
Figure 3
Protein expression of RVOT myocardium. (A): Hif-1α expression in the RIPC group is higher than that in the control group (P = 0.0008). (BE): RIPC group ratio of phosphorylated Akt (P = 0.0096), STAT3 (P = 0.0144), STAT5 (P = 0.0156), and eNOS (P = 0.0279) to total protein are higher than that in the control group. (F): Phosphorylated PTEN shows no difference between the groups. n = 20 in the control and n = 19 in the RIPC group. *P < 0.05 vs. control group.
Figure 4
Figure 4
Ultrastructure of RVOT myocardium. (A): All the mitochondria exhibit swelling, with one also showing vacuolization; (B): Mitochondria exhibit marked swelling; (C): A ruptured mitochondrion; (D): Distinct abnormal contraction of myofibrils; (E): Due to abnormal contraction, the myofibrils snapped; (F): The structure of the myofibrils were disrupted, with lysis at the centre. The typical ultrastructural changes of the myocardium are indicated by the arrow.
Figure 5
Figure 5
Schematic of proposed signalling involved in remote ischaemic preconditioning cardioprotection (RIPC) in ToF children undergoing elective radical ToF repair surgery. RIPC reduces the postoperative cardiac ischaemic injury through activating the PI3K/Akt and JAK/STAT3/5 signalling pathways, which is associated with nuclear accumulation of Hif-1a and STAT3/5 and subsequent induction of myocardial eNOS activation and mitochondrial protection.

References

    1. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166–175.
    1. Heusch G, Botker HE, Przyklenk K, Redington A, Yellon D.. Remote ischaemic conditioning. J Am Coll Cardiol 2015;65:177–195.
    1. Heusch G. Molecular basis of cardioprotection: signal transduction in ischaemic pre-, post-, and remote conditioning. Circ Res 2015;116:674–699.
    1. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN.. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277–2282.
    1. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM.. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007;370:575–579.
    1. Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G.. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 2013;382:597–604.
    1. Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM, Investigators ET.. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 2015;373:1408–1417.
    1. Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K, Collaborators RIS.. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 2015;373:1397–1407.
    1. Kleinbongard P, Neuhauser M, Thielmann M, Kottenberg E, Peters J, Jakob H, Heusch G.. Confounders of cardioprotection by remote ischaemic preconditioning in patients undergoing coronary artery bypass grafting. Cardiology 2016;133:128–133.
    1. Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G.. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischaemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg 2014;147:376–382.
    1. Hepponstall M, Ignjatovic V, Binos S, Attard C, Karlaftis V, D'udekem Y, Monagle P, Konstantinov IE.. Remote ischemic preconditioning (RIPC) modifies the plasma proteome in children undergoing repair of tetralogy of fallot: a randomized controlled trial. PLoS One 2015;10:e0122778..
    1. Azarfarin R, Ashouri N, Totonchi Z, Bakhshandeh H, Yaghoubi A.. Factors influencing prolonged ICU stay after open heart surgery. Res Cardiovasc Med 2014;3:e20159..
    1. Almashrafi A, Alsabti H, Mukaddirov M, Balan B, Aylin P.. Factors associated with prolonged length of stay following cardiac surgery in a major referral hospital in Oman: a retrospective observational study. BMJ Open 2016;6:e010764.
    1. Mahesh B, Choong CK, Goldsmith K, Gerrard C, Nashef SA, Vuylsteke A.. Prolonged stay in intensive care unit is a powerful predictor of adverse outcomes after cardiac operations. Ann Thorac Surg 2012;94:109–116.
    1. Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res 2010;1:67–69.
    1. Xia Z, Huang Z, Ansley DM.. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 2006;103:527–532.
    1. Schmiedl A, Schnabel PA, Mall G, Gebhard MM, Hunneman DH, Richter J, Bretschneider HJ.. The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Correlations during the course of myocardial global ischaemia. Virchows Arch a Pathol Anat Histopathol 1990;416:305–315.
    1. DiBona DR, Powell WJ. Jr.,. Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ Res 1980;47:653–665.
    1. Muhlfeld C, Richter J.. High-pressure freezing and freeze substitution of rat myocardium for immunogold labeling of connexin 43. Anat Rec a Discov Mol Cell Evol Biol 2006;288:1059–1067.
    1. Muhlfeld C, Coulibaly M, Dorge H, Sellin C, Liakopoulos O, Ballat C, Richter J, Schoendube F.. Ultrastructure of right ventricular myocardium subjected to acute pressure load. Thorac Cardiovasc Surg 2004;52:328–333.
    1. Healy DA, Boyle E, McCartan D, Bourke M, Medani M, Ferguson J, Yagoub H, Bashar K, O'donnell M, Newell J, Canning C, McMonagle M, Dowdall J, Cross S, O'daly S, Manning B, Fulton G, Kavanagh EG, Burke P, Grace PA, Moloney MC, Walsh SR.. A multicenter pilot randomized controlled trial of remote ischemic preconditioning in major vascular surgery. Vasc Endovascular Surg 2015;49:220–227.
    1. Tie HT, Luo MZ, Li ZH, Wang Q, Wu QC, Li Q, Zhang M.. Remote ischemic preconditioning fails to benefit pediatric patients undergoing congenital cardiac surgery: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 2015;94:e1895..
    1. Walsh M, Whitlock R, Garg AX, Legare JF, Duncan AE, Zimmerman R, Miller S, Fremes S, Kieser T, Karthikeyan G, Chan M, Ho A, Nasr V, Vincent J, Ali I, Lavi R, Sessler DI, Kramer R, Gardner J, Syed S, VanHelder T, Guyatt G, Rao-Melacini P, Thabane L, Devereaux PJ.. Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trial. CMAJ 2016;188:329–336.
    1. Heusch G, Gersh BJ.. ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not! Eur Heart J 2016;37:200–202.
    1. Heusch G, Rassaf T.. Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning. Circ Res 2016;119:676–695.
    1. Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J.. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol–a clinical trial. Acta Anaesthesiol Scand 2012;56:30–38.
    1. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT.. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375:727–734.
    1. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R.. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 2014;66:1142–1174.
    1. Boengler K, Schulz R, Heusch G.. Loss of cardioprotection with ageing. Cardiovasc Res 2009;83:247–261.
    1. Pedersen KR, Ravn HB, Povlsen JV, Schmidt MR, Erlandsen EJ, Hjortdal VE.. Failure of remote ischemic preconditioning to reduce the risk of postoperative acute kidney injury in children undergoing operation for complex congenital heart disease: a randomized single-center study. J Thorac Cardiovasc Surg 2012;143:576–583.
    1. McCrindle BW, Clarizia NA, Khaikin S, Holtby HM, Manlhiot C, Schwartz SM, Caldarone CA, Coles JG, Van Arsdell GS, Scherer SW, Redington AN.. Remote ischemic preconditioning in children undergoing cardiac surgery with cardiopulmonary bypass: a single-center double-blinded randomized trial. J Am Heart Assoc 2014;3:e000964.
    1. Pearl JM, Nelson DP, Wellmann SA, Raake JL, Wagner CJ, McNamara JL, Duffy JY.. Acute hypoxia and reoxygenation impairs exhaled nitric oxide release and pulmonary mechanics. J Thorac Cardiovasc Surg 2000;119:931–938.
    1. Schulze-Neick I, Li J, Penny DJ, Redington AN.. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 2001;121:1033–1039.
    1. Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J, MacAllister R.. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001;103:1624–1630.
    1. Cai ZP, Parajuli N, Zheng X, Becker L.. Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 2012;107:277..
    1. Kleinbongard P, Schulz R, Heusch G.. TNFalpha in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail Rev 2011;16:49–69.
    1. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH.. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 1999;27:1309–1318.
    1. Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, MacVittie TJ, Parrillo JE.. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823–832.
    1. Walley KR, Hebert PC, Wakai Y, Wilcox PG, Road JD, Cooper DJ.. Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs. J Appl Physiol 1985;76:1060–1067.
    1. Donnelly RP, Freeman SL, Hayes MP.. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J Immunol 1995;155:1420–1427.
    1. Ong SG, Hausenloy DJ.. Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacol Ther 2012;136:69–81.
    1. Prabhakar NR, Semenza GL.. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 2012;92:967–1003.
    1. Wang GL, Jiang BH, Rue EA, Semenza GL.. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995;92:5510–5514.
    1. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA.. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000;342:626–633.
    1. Albrecht M, Zitta K, Bein B, Wennemuth G, Broch O, Renner J, Schuett T, Lauer F, Maahs D, Hummitzsch L, Cremer J, Zacharowski K, Meybohm P.. Remote ischemic preconditioning regulates HIF-1alpha levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study. Basic Res Cardiol 2013;108:314..
    1. Amour J, Brzezinska AK, Weihrauch D, Billstrom AR, Zielonka J, Krolikowski JG, Bienengraeber MW, Warltier DC, Pratt PF Jr, Kersten JR.. Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology 2009;110:317–325.
    1. Lecour S. Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol 2009;47:32–40.
    1. Hausenloy DJ, Iliodromitis EK, Andreadou I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, Kremastinos DT, Yellon DM.. Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther 2012;26:87–93.
    1. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M.. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 2012;110:111–115.
    1. Pepe S, Liaw NY, Hepponstall M, Sheeran FL, Yong MS, D'udekem Y, Cheung MM, Konstantinov IE.. Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of Fallot repair: a randomized controlled trial. J Am Heart Assoc 2013;2:e000095..
    1. Liang Y, Li YP, He F, Liu XQ, Zhang JY.. Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart disease. Braz J Med Biol Res 2015;48:568–576.
    1. Di Lisa F, Bernardi P.. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006;70:191–199.
    1. Griffiths EJ, Halestrap AP.. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 1995;307: 93–98.
    1. Yellon DM, Hausenloy DJ.. Myocardial reperfusion injury. N Engl J Med 2007;357:1121–1135.
    1. Heusch G, Boengler K, Schulz R.. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 2010;105:151–154.

Source: PubMed

3
订阅